{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:28:48Z","timestamp":1780086528255,"version":"3.54.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T00:00:00Z","timestamp":1707004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ad.2023.07.028","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:52:32Z","timestamp":1707180752000},"page":"T341-T346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["[Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)"],"prefix":"10.1016","volume":"115","author":[{"given":"C.","family":"Couselo-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Batalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Carrascosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chicharro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gonz\u00e1lez-Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"de la Cueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Gim\u00e9nez-Arnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Gilaberte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rodr\u00edguez-Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Montero-Vilchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ruiz-Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Elosua-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Silvestre-Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Munera-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"S\u00e1nchez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Carretero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Maule\u00f3n-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Curto-Barredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ballano-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Botella-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Arias-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Navarro-Trivi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Roustan-Gull\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Betlloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"del Alc\u00e1zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Abalde-Pintos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Su\u00e1rez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Garc\u00eda-Doval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u00c1.","family":"Descalzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Fl\u00f3rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2023.07.028_bib0105","doi-asserted-by":"crossref","first-page":"e13979","DOI":"10.1111\/dth.13979","article-title":"Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients","volume":"33","author":"Dal Bello","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.07.028_bib0110","doi-asserted-by":"crossref","first-page":"adv00161","DOI":"10.2340\/00015555-3511","article-title":"Counting the Burden: Atopic Dermatitis and Health-related Quality of Life","volume":"100","author":"Ali","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2023.07.028_bib0115","first-page":"93","article-title":"Atopic dermatitis and psychosocial comorbidities","volume":"18","author":"Kage","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ad.2023.07.028_bib0120","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s13555-021-00519-7","article-title":"Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control Study","volume":"11","author":"Toron","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.ad.2023.07.028_bib0125","unstructured":"BIFIMED: Buscador de la Informaci\u00f3n sobre la situaci\u00f3n de financiaci\u00f3n de los medicamentos. [consulted on April 29, 2023]. Available from https:\/\/www.sanidad.gob.es\/gl\/profesionales\/medicamentos.do"},{"key":"10.1016\/j.ad.2023.07.028_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ad.2023.05.010","article-title":"BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings","author":"Munera-Campos","year":"2023","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2023.07.028_bib0135","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/jdv.13682","article-title":"Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis","volume":"30","author":"D\u00e1vila-Seijo","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.07.028_bib0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ad.2010.10.016","article-title":"BIOBADADERM, the Spanish Registry of Adverse Events Associated with Biologic Drugs in Dermatology: first report","volume":"102","author":"Rivera","year":"2011","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2023.07.028_bib0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archdermatol.2011.2768","article-title":"Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials","volume":"148","author":"Garc\u00eda-Doval","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2023.07.028_bib0150","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/jdv.14880","article-title":"Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine","volume":"32","author":"Law Ping Man","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.07.028_bib0155","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1080\/09546634.2022.2067818","article-title":"Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study","volume":"33","author":"Napolitano","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2023.07.028_bib0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/bjd.13961","article-title":"Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis","volume":"174","author":"Politiek","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.07.028_bib0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/bjd.19428","article-title":"Drug survival of systemic and biological treatments for moderate-to-severe atopic dermatitis in adults: a multicentre retrospective observational study","volume":"184","author":"Pereyra-Rodriguez","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.07.028_bib0170","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.18889","article-title":"Long-term drug survival of dupilumab and associated predictors in moderate-to-severe atopic dermatitis: A real-world prospective cohort study","author":"Pezzolo","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.07.028_bib0175","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ijwd.2021.07.005","article-title":"Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort","volume":"7","author":"Elsgaard","year":"2021","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.ad.2023.07.028_bib0180","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/all.14324","article-title":"Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry","volume":"75","author":"Spekhorst","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2023.07.028_bib0185","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/bjd.13730","article-title":"Drug survival for ciclosporin A in a long-term daily practice cohort of adult patients with atopic dermatitis","volume":"172","author":"Van der Schaft","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.07.028_bib0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaad.2020.03.033","article-title":"Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry","volume":"83","author":"Daud\u00e9n","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.07.028_bib0195","doi-asserted-by":"crossref","first-page":"11S12","DOI":"10.1016\/S0151-9638(20)31083-8","article-title":"Les scores d\u2019\u00e9valuation de la dermatite atopique: Outcome measures for atopic dermatitis","volume":"147","author":"Lacour","year":"2020","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.07.028_bib0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ad.2016.09.001","article-title":"Drug Survival Analysis Is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis","volume":"108","author":"D\u00e1vila-Seijo","year":"2017","journal-title":"Actas Dermosifiliogr"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024000826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024000826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T19:42:49Z","timestamp":1720554169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731024000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0001731024000826"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2023.07.028","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.07.014","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}